Euromedis Groupe SA
Laboratoires Euromedis Société anonyme manufactures, imports, and distributes single-use medical devices for public and private healthcare facilities. It provides gloves; clothing and protection; draping and fields; compresses, cotton, dressings, strips and nets, and skincare products; sets and instrumentation; needles, syringes, microperfusionists; infusion and transfusion services, catheters, a… Read more
Market Cap & Net Worth: Euromedis Groupe SA (ALEMG)
Euromedis Groupe SA (PA:ALEMG) has a market capitalization of $13.93 Million (€13.57 Million) as of March 18, 2026. Listed on the PA stock exchange, this France-based company holds position #31359 globally and #338 in its home market, demonstrating a 0.21% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Euromedis Groupe SA's stock price €4.77 by its total outstanding shares 2844222 (2.84 Million).
Euromedis Groupe SA Market Cap History: 2015 to 2026
Euromedis Groupe SA's market capitalization history from 2015 to 2026. Data shows change from $18.20 Million to $13.93 Million (-2.77% CAGR).
Euromedis Groupe SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Euromedis Groupe SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.35x
Euromedis Groupe SA's market cap is 0.35 times its annual revenue
0.29x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $18.20 Million | $71.19 Million | $2.47 Million | 0.26x | 7.36x |
| 2016 | $20.29 Million | $73.17 Million | $1.01 Million | 0.28x | 20.15x |
| 2017 | $20.96 Million | $73.60 Million | -$146.00K | 0.28x | N/A |
| 2018 | $19.27 Million | $76.06 Million | -$4.92 Million | 0.25x | N/A |
| 2019 | $13.25 Million | $77.08 Million | -$3.80 Million | 0.17x | N/A |
| 2020 | $40.00 Million | $193.41 Million | $22.66 Million | 0.21x | 1.76x |
| 2021 | $30.65 Million | $111.90 Million | $2.26 Million | 0.27x | 13.59x |
| 2022 | $14.04 Million | $54.18 Million | -$5.96 Million | 0.26x | N/A |
| 2023 | $15.53 Million | $37.43 Million | $13.11 Million | 0.41x | 1.18x |
| 2024 | $12.85 Million | $36.22 Million | -$6.11 Million | 0.35x | N/A |
Competitor Companies of ALEMG by Market Capitalization
Companies near Euromedis Groupe SA in the global market cap rankings as of March 18, 2026.
Key companies related to Euromedis Groupe SA by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #165 globally with a market cap of $115.21 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #350 globally with a market cap of $62.31 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #430 globally with a market cap of $50.81 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1462 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | McKesson Corporation | NYSE:MCK | $115.21 Billion | $941.89 |
| #350 | Cencora Inc. | NYSE:COR | $62.31 Billion | $334.71 |
| #430 | Cardinal Health Inc | NYSE:CAH | $50.81 Billion | $216.36 |
| #1462 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Euromedis Groupe SA Historical Marketcap From 2015 to 2026
Between 2015 and today, Euromedis Groupe SA's market cap moved from $18.20 Million to $ 13.93 Million, with a yearly change of -2.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.93 Million | +21.68% |
| 2025 | €11.44 Million | -10.91% |
| 2024 | €12.85 Million | -17.29% |
| 2023 | €15.53 Million | +10.60% |
| 2022 | €14.04 Million | -54.19% |
| 2021 | €30.65 Million | -23.36% |
| 2020 | €40.00 Million | +201.76% |
| 2019 | €13.25 Million | -31.21% |
| 2018 | €19.27 Million | -8.08% |
| 2017 | €20.96 Million | +3.32% |
| 2016 | €20.29 Million | +11.48% |
| 2015 | €18.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Euromedis Groupe SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.93 Million USD |
| MoneyControl | $13.93 Million USD |
| MarketWatch | $13.93 Million USD |
| marketcap.company | $13.93 Million USD |
| Reuters | $13.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.